Koesten Hirschmann & Crabtree’s Adient ADNT Stock Holding History

Koesten Hirschmann & Crabtree’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6	Closed	-$123	–	266
2025 Q2	$123	Buy	+6	New	+$89	﹤0.01%	322

Other funds holding ADNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HHAM

HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return

Koesten Hirschmann & Crabtree's ADNT Position: Q3 2025 in Review

Koesten Hirschmann & Crabtree sold out of Adient (ADNT) in Q3 2025, closing a stake of 6 shares — an estimated $123 sold.

Koesten Hirschmann & Crabtree first reported a position in ADNT in Q2 2025 and held it in 1 quarter. The position peaked at $123 in Q2 2025. 287 funds tracked by Wall St. Rank hold ADNT as of Q3 2025.

Koesten Hirschmann & Crabtree reported no remaining Adient position as of Q3 2025 after selling out during the quarter.
Koesten Hirschmann & Crabtree sold 6 Adient shares in Q3 2025, an estimated $123.
Koesten Hirschmann & Crabtree first reported a position in Adient in Q2 2025 and held it in 1 quarter.
Koesten Hirschmann & Crabtree's Adient position peaked at $123 in Q2 2025.
287 funds tracked by Wall St. Rank held Adient as of Q3 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q3 2025, filed 5 Nov 2025.